- Home
- CCEL vs CNVS Comparison
CCEL vs CNVS Comparison
Compare CCEL & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- CNVS
- Stock Information
- Founded
- CCEL 1989
- CNVS 2000
- Country
- CCEL United States
- CNVS United States
- Employees
- CCEL N/A
- CNVS N/A
- Industry
- CCEL Managed Health Care
- CNVS Consumer Electronics/Video Chains
- Sector
- CCEL Health Care
- CNVS Consumer Discretionary
- Exchange
- CCEL Nasdaq
- CNVS Nasdaq
- Market Cap
- CCEL 51.9M
- CNVS N/A
- IPO Year
- CCEL 1997
- CNVS 2003
- Fundamental
- Price
- CCEL $5.56
- CNVS $2.96
- Analyst Decision
- CCEL Strong Buy
- CNVS Buy
- Analyst Count
- CCEL 1
- CNVS 1
- Target Price
- CCEL $8.50
- CNVS $10.00
- AVG Volume (30 Days)
- CCEL 12.2K
- CNVS 72.8K
- Earning Date
- CCEL 04-15-2025
- CNVS 02-13-2025
- Dividend Yield
- CCEL 4.45%
- CNVS N/A
- EPS Growth
- CCEL N/A
- CNVS N/A
- EPS
- CCEL 0.01
- CNVS N/A
- Revenue
- CCEL $32,102,750.00
- CNVS $72,469,000.00
- Revenue This Year
- CCEL $2.49
- CNVS $59.61
- Revenue Next Year
- CCEL $0.95
- CNVS N/A
- P/E Ratio
- CCEL $346.31
- CNVS N/A
- Revenue Growth
- CCEL 2.33
- CNVS 39.86
- 52 Week Low
- CCEL $4.96
- CNVS $0.72
- 52 Week High
- CCEL $9.50
- CNVS $4.89
- Technical
- Relative Strength Index (RSI)
- CCEL 40.47
- CNVS 48.70
- Support Level
- CCEL $5.38
- CNVS $2.93
- Resistance Level
- CCEL $5.93
- CNVS $3.20
- Average True Range (ATR)
- CCEL 0.40
- CNVS 0.19
- MACD
- CCEL 0.04
- CNVS 0.06
- Stochastic Oscillator
- CCEL 50.00
- CNVS 71.01
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.